These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37537576)

  • 1. Plasma lipidic fingerprint associated with type 2 diabetes in patients with coronary heart disease: CORDIOPREV study.
    Villasanta-Gonzalez A; Mora-Ortiz M; Alcala-Diaz JF; Rivas-Garcia L; Torres-Peña JD; Lopez-Bascon A; Calderon-Santiago M; Arenas-Larriva AP; Priego-Capote F; Malagon MM; Eichelmann F; Perez-Martinez P; Delgado-Lista J; Schulze MB; Camargo A; Lopez-Miranda J
    Cardiovasc Diabetol; 2023 Aug; 22(1):199. PubMed ID: 37537576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A plasma fatty acid profile associated to type 2 diabetes development: from the CORDIOPREV study.
    Villasanta-Gonzalez A; Alcala-Diaz JF; Vals-Delgado C; Arenas AP; Cardelo MP; Romero-Cabrera JL; Rodriguez-Cantalejo F; Delgado-Lista J; Malagon MM; Perez-Martinez P; Schulze MB; Camargo A; Lopez-Miranda J
    Eur J Nutr; 2022 Mar; 61(2):843-857. PubMed ID: 34609622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between cholesterol efflux capacity and peripheral artery disease in coronary heart disease patients with and without type 2 diabetes: from the CORDIOPREV study.
    Yubero-Serrano EM; Alcalá-Diaz JF; Gutierrez-Mariscal FM; Arenas-de Larriva AP; Peña-Orihuela PJ; Blanco-Rojo R; Martinez-Botas J; Torres-Peña JD; Perez-Martinez P; Ordovas JM; Delgado-Lista J; Gómez-Coronado D; Lopez-Miranda J
    Cardiovasc Diabetol; 2021 Mar; 20(1):72. PubMed ID: 33766036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiRNAs profile as biomarkers of nutritional therapy for the prevention of type 2 diabetes mellitus: From the CORDIOPREV study.
    Jimenez-Lucena R; Alcala-Diaz JF; Roncero-Ramos I; Lopez-Moreno J; Camargo A; Gomez-Delgado F; Quintana-Navarro GM; Vals-Delgado C; Rodriguez-Cantalejo F; Luque RM; Delgado-Lista J; Ordovas JM; Perez-Martinez P; Rangel-Zuñiga OA; Lopez-Miranda J
    Clin Nutr; 2021 Mar; 40(3):1028-1038. PubMed ID: 32723508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postprandial endotoxemia may influence the development of type 2 diabetes mellitus: From the CORDIOPREV study.
    Camargo A; Jimenez-Lucena R; Alcala-Diaz JF; Rangel-Zuñiga OA; Garcia-Carpintero S; Lopez-Moreno J; Blanco-Rojo R; Delgado-Lista J; Perez-Martinez P; van Ommen B; Malagon MM; Ordovas JM; Perez-Jimenez F; Lopez-Miranda J
    Clin Nutr; 2019 Apr; 38(2):529-538. PubMed ID: 29685478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma Lipidome and Prediction of Type 2 Diabetes in the Population-Based Malmö Diet and Cancer Cohort.
    Fernandez C; Surma MA; Klose C; Gerl MJ; Ottosson F; Ericson U; Oskolkov N; Ohro-Melander M; Simons K; Melander O
    Diabetes Care; 2020 Feb; 43(2):366-373. PubMed ID: 31818810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An altered microbiota pattern precedes Type 2 diabetes mellitus development: From the CORDIOPREV study.
    Vals-Delgado C; Alcala-Diaz JF; Molina-Abril H; Roncero-Ramos I; Caspers MPM; Schuren FHJ; Van den Broek TJ; Luque R; Perez-Martinez P; Katsiki N; Delgado-Lista J; Ordovas JM; van Ommen B; Camargo A; Lopez-Miranda J
    J Adv Res; 2022 Jan; 35():99-108. PubMed ID: 35024196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A set of miRNAs predicts T2DM remission in patients with coronary heart disease: from the CORDIOPREV study.
    Rangel-Zuñiga OA; Vals-Delgado C; Alcala-Diaz JF; Quintana-Navarro GM; Krylova Y; Leon-Acuña A; Luque RM; Gomez-Delgado F; Delgado-Lista J; Ordovas JM; Perez-Martinez P; Camargo A; Lopez-Miranda J
    Mol Ther Nucleic Acids; 2021 Mar; 23():255-263. PubMed ID: 33425484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomics analysis of type 2 diabetes remission identifies 12 metabolites with predictive capacity: a CORDIOPREV clinical trial study.
    Mora-Ortiz M; Alcala-Diaz JF; Rangel-Zuñiga OA; Arenas-de Larriva AP; Abollo-Jimenez F; Luque-Cordoba D; Priego-Capote F; Malagon MM; Delgado-Lista J; Ordovas JM; Perez-Martinez P; Camargo A; Lopez-Miranda J
    BMC Med; 2022 Oct; 20(1):373. PubMed ID: 36289459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta cell functionality and hepatic insulin resistance are major contributors to type 2 diabetes remission and starting pharmacological therapy: from CORDIOPREV randomized controlled trial.
    Roncero-Ramos I; Gutierrez-Mariscal FM; Gomez-Delgado F; Villasanta-Gonzalez A; Torres-Peña JD; Cruz-Ares S; Rangel-Zuñiga OA; Luque RM; Ordovas JM; Delgado-Lista J; Perez-Martinez P; Camargo A; Alcalá-Diaz JF; Lopez-Miranda J
    Transl Res; 2021 Dec; 238():12-24. PubMed ID: 34298148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between Diet Quality and Risk of Type 2 Diabetes Mellitus in Patients with Coronary Heart Disease: Findings from the CORDIOPREV Study.
    Rivas-Garcia L; Quintana-Navarro GM; Alcala-Díaz JF; Torres-Peña JD; Arenas-de Larriva AP; Rangel-Zuñiga OA; López-Moreno A; Malagon MM; Katsiki N; Perez-Martinez P; Lopez-Miranda J; Delgado-Lista J
    Nutrients; 2024 Apr; 16(8):. PubMed ID: 38674939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic insulin resistance both in prediabetic and diabetic patients determines postprandial lipoprotein metabolism: from the CORDIOPREV study.
    Leon-Acuña A; Alcala-Diaz JF; Delgado-Lista J; Torres-Peña JD; Lopez-Moreno J; Camargo A; Garcia-Rios A; Marin C; Gomez-Delgado F; Caballero J; Van-Ommen B; Malagon MM; Perez-Martinez P; Lopez-Miranda J
    Cardiovasc Diabetol; 2016 Apr; 15():68. PubMed ID: 27095446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Establishing a noninvasive prediction model for type 2 diabetes mellitus based on a rural Chinese population].
    Zhang HY; Shi WH; Zhang M; Yin L; Pang C; Feng TP; Zhang L; Ren YC; Wang BY; Yang XY; Zhou JM; Han CY; Zhao Y; Zhao JZ; Hu DS
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 May; 50(5):397-403. PubMed ID: 27141894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
    Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
    EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dysregulation of glucose metabolism control is associated with carotid atherosclerosis in patients with coronary heart disease (CORDIOPREV-DIAB study).
    Yubero-Serrano EM; Delgado-Lista J; Alcala-Diaz JF; Garcia-Rios A; Perez-Caballero AI; Blanco-Rojo R; Gomez-Delgado F; Marin C; Tinahones FJ; Caballero J; Ordovas JM; van Ommen B; Perez-Jimenez F; Perez-Martinez P; Lopez-Miranda J
    Atherosclerosis; 2016 Oct; 253():178-185. PubMed ID: 27451413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between serum Sestrin2 and the risk of coronary heart disease in patients with type 2 diabetes mellitus.
    Tian X; Gao Y; Zhong M; Kong M; Zhao L; Feng Z; Sun Q; He J; Liu X
    BMC Cardiovasc Disord; 2022 Jun; 22(1):281. PubMed ID: 35729499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low Serum Dehydroepiandrosterone and Dehydroepiandrosterone Sulfate Are Associated With Coronary Heart Disease in Men With Type 2 Diabetes Mellitus.
    Zhang X; Xiao J; Liu T; He Q; Cui J; Tang S; Li X; Liu M
    Front Endocrinol (Lausanne); 2022; 13():890029. PubMed ID: 35832423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a risk prediction model for diabetic retinopathy in type 2 diabetic patients.
    Zhu C; Zhu J; Wang L; Xiong S; Zou Y; Huang J; Xie H; Zhang W; Wu H; Liu Y
    Sci Rep; 2023 Mar; 13(1):5034. PubMed ID: 36977687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of simple clinical parameters to predict insulin resistance among newly diagnosed patients with type 2 diabetes in limited resource settings.
    Wasana KGP; Attanayake AP; Weerarathna TP; Jayatilaka KAPW
    PLoS One; 2021; 16(3):e0248469. PubMed ID: 33788827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipidome as a predictive tool in progression to type 2 diabetes in Finnish men.
    Suvitaival T; Bondia-Pons I; Yetukuri L; Pöhö P; Nolan JJ; Hyötyläinen T; Kuusisto J; Orešič M
    Metabolism; 2018 Jan; 78():1-12. PubMed ID: 28941595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.